research use only

Tinostamustine(EDO-S101) HDAC inhibitor

Cat.No.S8769

Tinostamustine (EDO-S101) is a first-in-class alkylating deacetylase inhibitor, with IC50 values of 9 nM, 9 nM, 25 nM, and 107 nM for HDAC1, HDAC2, HDAC3, and HDAC8 (Class 1 HDACs), respectively, and 6 nM and 72 nM for HDAC6 and HDAC10 (Class II HDACs).
Tinostamustine(EDO-S101) HDAC inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 415.36

Jump to

Quality Control

Batch: S876901 DMSO]14 mg/mL]false]Ethanol]2 mg/mL]false]Water]Insoluble]false Purity: 99.7%
99.7

Solubility

In vitro
Batch:

DMSO : 14 mg/mL (33.7 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 2 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 415.36 Formula

C19H28Cl2N4O2

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 1236199-60-2 -- Storage of Stock Solutions

Synonyms N/A Smiles CN1C2=C(C=C(C=C2)N(CCCl)CCCl)N=C1CCCCCCC(=O)NO

Mechanism of Action

Targets/IC50/Ki
HDAC6
(Cell-free assay)
6 nM
HDAC1
(Cell-free assay)
9 nM
HDAC2
(Cell-free assay)
9 nM
HDAC3
(Cell-free assay)
25 nM
HDAC10
(Cell-free assay)
72 nM
HDAC8
(Cell-free assay)
107 nM
In vitro

In 8 myeloma cell lines, the IC50s of Tinostamustine (EDO-S101) range between 5–13 μM. It has significant synergistic cytotoxicity with the proteasome inhibitors bortezomib and carfilzomib across all cell types tested. This compound induces strong protein and histone acetylation and is a strong inducer of pIRE-1, the key activator protein of the UPR in MM cells.

References

Applications

Methods Biomarkers Images PMID
Western blot pATR / pCHK1 / pATM / pCHK2 / p53 / γH2AX Ac-H3 / Ac-H4 / Ac α-tubulin caspase-8 / caspase-9 / caspase-7 / caspase-3 / PARP AIF / COX IV NOXA / p-MCL1 / p-S-BCL2 / BCL2
S8769-WB1
28633670
Immunofluorescence γH2AX / Rad51
S8769-IF1
28633670
Growth inhibition assay Cell viability
S8769-viability1
28633670

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT03903458 Unknown status
Malignant Melanoma
Markus Joerger|Cantonal Hospital of St. Gallen
March 7 2019 Phase 1

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map